King Bio Inc. Recalls Multi-Strain Flu Relief Due to Microbial Contamination
King Bio Inc. is recalling Dr. King's Natural Medicine Multi-Strain Flu Relief bottles due to microbial contamination. The product was distributed in the U.S., Canada, and Australia.
The agency’s classification
FDA (Drugs): Class I
Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class I, which mandates a minimum severity score of 4 according to the rubric.
Plain-English summary
King Bio Inc. is recalling specific lots of Dr. King's Natural Medicine Multi-Strain Flu Relief, 59 mL liquid. The recall is being conducted because the product is subject to microbial contamination.
The affected product includes 2,940 bottles with lot numbers 011416H (expiration 01/19) and 081516E (expiration 08/19). The product was distributed nationwide in the United States, as well as in Canada and Australia.
Consumers who have purchased this product should stop using it and contact the manufacturer for further instructions or a refund.
The recalled product
- Product
- Dr. King's Natural Medicine Multi-Strain Flu Relief, 59 mL, (liquid/liquid), DIN-HM 80038065 UPC 357955180128
- Manufacturer
- King Bio Inc.
- Category
- Drug — Homeopathic Medicine
- Hazard
- Affected units
- 2,940
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lots: 011416H Exp. 01/19
- 081516E Exp. 08/19
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 465 recalled by King Bio Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 465 products in this recall →Related recalls
Same manufacturer · King Bio Inc.
See all →- CriticalKing Bio Recalls Dr. King's SafeCare Rx Calloused Due to Microbial Contamination
FDA (Drugs) · 2019-03-20
- SevereKing Bio Homeopathic Allergy Spray Recalled for Microbial Contamination
FDA (Drugs) · 2019-03-20
- CriticalKing Bio Recalls Heartburn Relief for Microbial Contamination
FDA (Drugs) · 2019-03-20
- SevereKing Bio Homeopathic Allergy Product Recalled for Microbial Contamination
FDA (Drugs) · 2019-03-20
- CriticalDr. King's Advanced Arnica Recalled for Microbial Contamination
FDA (Drugs) · 2019-03-20
Same hazard · microbial contamination
See all →- HighSV Labs Recalls Benzoyl Peroxide Wash Due to Microbial Contamination
FDA (Drugs) · 2026-10-07
- HighSV Labs Recalls Benzoyl Peroxide Wash Due to Microbial Contamination
FDA (Drugs) · 2026-10-07
- SevereMedline Ultrasound Breast Pack Recalled for Potential Sterility Breach
FDA (Devices) · 2026-09-09
- HighMedline Convenience Kits Recalled for Potential Sterility Breach
FDA (Devices) · 2026-09-09
- CriticalOptimal Balance Pharmacy Recalls Contaminated Glutathione Injection Vials
FDA (Drugs) · 2026-09-09
Similar recalls
- HighSprayology Recalls Cold + Flu Relief Homeopathic Oral Spray
FDA (Drugs) · 2018-11-07
- SevereKingston Pharma Recalls Infant Cough Syrup Due to Microbial Contamination
FDA (Food) · 2019-05-08
- SevereKey Pharmacy Recalls Methyl-B12 Injections Due to Sterility Concerns
FDA (Drugs) · 2017-05-24
- SevereGeritrex Recalls Ritussin DM Due to Potential Microbial Contamination
FDA (Drugs) · 2019-07-31
- SevereFranck's Lab Recalls Sterile Lidocaine Drugs Due to Microbial Contamination
FDA (Drugs) · 2012-08-22
- SevereKey Pharmacy Recalls Hydroxo-B12 Injections Due to Sterility Concerns
FDA (Drugs) · 2017-05-24